IMATINIB MESYLATE
- Product NDC
- 51991-377
- 11-digit product format
- 519910377
- Labeler code
- 51991
- Product ID
- 51991-377_33a6c95d-ec44-461c-9eef-a771aa0981ac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- IMATINIB MESYLATE
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Application
- ANDA205990
- Marketing category
- ANDA
- Marketing start
- 2019-02-08
- Marketing end
- 2023-06-30
- Substance
- IMATINIB MESYLATE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51991-377-05 | 51991037705 | 500 TABLET, COATED in 1 BOTTLE (51991-377-05) | 2019-02-08 | 2023-06-30 | No | No | Current |
| 51991-377-33 | 51991037733 | 30 TABLET, COATED in 1 BOTTLE (51991-377-33) | 2019-02-08 | 2023-06-30 | No | No | Current |
| 51991-377-90 | 51991037790 | 90 TABLET, COATED in 1 BOTTLE (51991-377-90) | 2019-02-08 | 2023-06-30 | No | No | Current |